Antibacterial material surfaces/interfaces for biomedical applications
Source abstract
Abstract
Abstract Biomaterial central infection (BCI) is a tough problem that has attracted high attention. The most common source of infection in biomaterial centers is bacterial infections. For the past few years, research on antibacterial material surfaces/interfaces has been particularly focused on reducing the initial bacterial adhesion and inhibiting the subsequent biofilm formation. Curtly, such surfaces/interfaces can be split into three primary kinds: antiadhesion-based antibacterial material surfaces/interfaces, release-based antibacterial material surfaces/interfaces, and contact-based antibacterial material surfaces/interfaces. In this review, we also describe the use of dual-function antibacterial biomaterial surfaces/interfaces, according to two strategies to form systems that kill attached bacteria, resist or release them, and other antibacterial materials in biomedicine applications. The future research direction of smart antibacterial material surfaces/interfaces design prospects.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bacterial biofilms and quorum sensing · Antimicrobial agents and applications · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Anionic surfactant-facilitated coating of antimicrobial peptide and antibiotic reduces biomaterial-associated infection10.1021/acsbiomaterials.0c00716 ↗
2. Urinary catheter indwelling clinical pathogen biofilm formation, exopolysaccharide characterization and their growth influencing parameters10.1016/j.sjbs.2015.04.016 ↗
3. Infection burden in total hip and knee arthroplasties: an international registry-based perspective10.1016/j.artd.2017.05.003 ↗
4. Biomaterials against bone infection
5. Materials for hip prostheses: a review of wear and loading considerations10.3390/ma12030495 ↗
6. Differential susceptibility of catheter biomaterials to biofilm-associated infections and their remedy by drug-encapsulated eudragit RL100 nanoparticles10.3390/ijms20205110 ↗
7. Dual-function antibacterial micelle via self-assembling block copolymers with various antibacterial nanoparticles10.1021/acsomega.9b04086 ↗
8. Bostrycin, a novel coupling agent for protein immobilization and prevention of biomaterial-centered infection produced by Nigrospora sp. No. 40710.1016/j.enzmictec.2012.02.002 ↗
9. Studies of the properties of CHG-Loaded alginate fibers for medical application10.1016/j.polymertesting.2019.106141 ↗
10. Implant infections: adhesion, biofilm formation and immune evasion10.1038/s41579-018-0019-y ↗
11. A self-sterilizing fluorescent nanocomposite as versatile material with broad-spectrum antibiofilm features10.1016/j.msec.2020.111308 ↗
12. Nanomaterials for treating bacterial biofilms on implantable medical devices10.3390/nano10112253 ↗
13. Analytical challenges of microbial biofilms on medical devices10.1021/ac2029997 ↗
14. Protein resistant polymeric biomaterials10.1021/acsmacrolett.7b00448 ↗
15. Combating medical device fouling10.1016/j.tibtech.2013.12.004 ↗
16. Biofilm formation on dental implants with different surface micro-topography: An in vitro study10.1111/clr.13455 ↗
17. Collagen scaffolds functionalised with copper-eluting bioactive glass reduce infection and enhance osteogenesis and angiogenesis both in vitro and in vivo10.1016/j.biomaterials.2019.01.031 ↗
18. Poly-tetrahydropyrimidine Antibacterial Hydrogel with Injectability and Self-Healing Ability for curing the purulent subcutaneous infection10.1021/acsami.0c13822 ↗
19. Preparation, characterization, and antibacterial properties of biofilms comprising chitosan and ε-polylysine10.1016/j.ijbiomac.2019.09.035 ↗
20. Organism Profile in Periprosthetic Joint Infection: pathogens differ at two arthroplasty infection referral centers in europe and in the United States10.1055/s-0033-1364102 ↗
21. Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile10.1016/j.arth.2013.09.053 ↗
22. Effect of oxygen plasma immersion ion implantation treatment on corrosion resistance and cell adhesion of titanium surface10.1111/j.1600-0501.2010.02132.x ↗
23. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective?10.1128/AAC.06246-11 ↗
24. Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves10.1093/eurheartj/ehz175 ↗
25. Pathogenicity and virulence of Staphylococcus aureus10.1080/21505594.2021.1878688 ↗
26. Mouse model of hematogenous implant-related Staphylococcus aureus biofilm infection reveals therapeutic targets
27. Staphylococcus aureus biofilms: recent developments in biofilm dispersal10.3389/fcimb.2014.00178 ↗
28. A nanostructured anti-biofilm surface widens the efficacy against spindle-shaped and chain-forming rod-like bacteria10.1039/D0NR03809A ↗
29. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials10.1016/j.biomaterials.2012.05.031 ↗
30. Improved hemocompatibility and reduced bacterial adhesion on superhydrophobic titania nanoflower surfaces10.1016/j.msec.2020.111503 ↗
31. Bacterial infection microenvironment-responsive enzymatically degradable multilayer films for multifunctional antibacterial properties10.1039/C7TB02114C ↗
32. Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats10.1016/j.biomaterials.2016.05.039 ↗
33. Antimicrobial and antifouling strategies for polymeric medical devices10.1021/acsmacrolett.7b00879 ↗
34. Medical device-induced thrombosis: what causes it and how can we prevent it?10.1111/jth.12961 ↗
35. Practical preparation of infection-resistant biomedical surfaces from antimicrobial β-peptide polymers10.1021/acsami.9b02915 ↗
36. Opportunities and challenges for the development of polymer-based biomaterials and medical devices10.1093/rb/rbw008 ↗
37. Economic burden of healthcare-associated infection in US acute care hospitals: societal perspective10.3111/13696998.2013.842922 ↗
38. Economic burden of periprosthetic joint infection in the United States10.1016/j.arth.2012.02.022 ↗
39. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial10.1016/j.bja.2019.01.038 ↗
40. Colonization frequency, endophytic infection rate and bioactivities of microbes of desert medicinal plants
41. Antimicrobial treatment concepts for orthopaedic device-related infection10.1111/1469-0691.12003 ↗
42. Self-defensive antimicrobial biomaterial surfaces10.1016/j.colsurfb.2020.110989 ↗
43. Periprosthetic joint infection increases the risk of one-year mortality10.2106/JBJS.L.00789 ↗
44. Clinical practice. Infections of cardiovascular implantable electronic devices10.1056/NEJMcp1107675 ↗
45. Healthcare-associated Infections: epidemiology, prevention, and therapy10.1002/msj.20070 ↗
46. Multistate point-prevalence survey of health care-associated infections10.1056/NEJMoa1306801 ↗
47. Antibiotic resistance of S. aureus on a ‘bifunctional’ surface: an in vitro coculture study10.1016/j.matlet.2020.128542 ↗
48. Antimicrobial efficiency of PAA/(PVP/CHI) erodible polysaccharide multilayer through loading and controlled release of antibiotics10.1016/j.carbpol.2016.12.054 ↗
49. Development of systemic immune dysregulation in a rat trauma model of biomaterial-associated infection10.1016/j.biomaterials.2020.120405 ↗
50. Novel strategies for the prevention and treatment of biofilm related infections10.3390/ijms140918488 ↗
51. Inhibition of bacterial adherence to biomaterials by coating antimicrobial peptides with anionic surfactant10.1016/j.colsurfb.2020.111364 ↗
52. Infection in ventricular assist devices: the role of biofilm10.1016/j.carpath.2006.04.008 ↗
53. Antibacterial activity of ordered gold nanorod arrays10.1021/am503153v ↗
54. Assessment of polycyclic aromatic hydrocarbon contamination in the Sundarbans, the world's largest tidal mangrove forest and indigenous microbial mixed biofilm-based removal of the contaminants10.1016/j.envpol.2020.115270 ↗
55. Durable and refreshable polymeric N-halamine biocides containing 3-(4 '-vinylbenzyl)-5,5-dimethylhydantoin10.1002/pola.1317 ↗
56. Antimicrobial property of halogenated catechols10.1016/j.cej.2020.126340 ↗
57. A review of the biomaterials technologies for infection-resistant surfaces10.1016/j.biomaterials.2013.07.089 ↗
58. Antibacterial surface design-contact kill10.1016/j.progsurf.2016.09.001 ↗
59. Responsive and synergistic antibacterial coatings: fighting against bacteria in a smart and effective way
60. Bioinspired interface design modulates pathogen and immunocyte responses in biomaterial-centered infection combination therapy10.1039/C8MH01606B ↗
61. Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review10.1016/j.jhin.2015.09.008 ↗
62. Natural and bioinspired nanostructured bactericidal surfaces10.1016/j.cis.2017.07.030 ↗
63. Antimicrobial coatings produced by “tethering” biocides to the coating matrix: A comprehensive review10.1016/j.porgcoat.2011.07.004 ↗
64. Versatile antibacterial materials: an emerging arsenal for combatting bacterial pathogens10.1002/adfm.201802140 ↗
65. Antimicrobial and antioxidant amphiphilic random copolymers to address medical device-centered infections10.1016/j.actbio.2015.04.023 ↗
66. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces10.1016/j.actbio.2010.11.005 ↗
67. Antibacterial and biocompatible cross-linked waterborne polyurethanes containing gemini quaternary ammonium salts10.1021/acs.biomac.7b01016 ↗
68. A coating that combines lotus-effect and contact-active antimicrobial properties on silicone10.1002/adfm.201801248 ↗
69. A shape-adaptive, antibacterial-coating of immobilized quaternary-ammonium compounds tethered on hyperbranched polyurea and its mechanism of action10.1002/adfm.201301686 ↗
70. The synthesis and characterization of carboxybetaine functionalized polysiloxanes for the preparation of anti-fouling surfaces10.1039/C4RA09171J ↗
71. Formation of contact active antimicrobial surfaces by covalent grafting of quaternary ammonium compounds10.1016/j.colsurfb.2018.04.065 ↗
72. Highly efficient antimicrobial and antifouling surface coatings with triclosan-loaded nanogels10.1021/acsami.0c18172 ↗
73. Recent developments in antimicrobial polymers: a review10.3390/ma9070599 ↗
74. Synthesis and antibacterial study of sulfobetaine/quaternary ammonium-modified star-shaped poly[2-(dimethylamino)ethyl methacrylate]-based copolymers with an inorganic core10.1021/acs.biomac.6b01279 ↗
75. Antimicrobial silver nanomaterials10.1016/j.ccr.2017.11.019 ↗
76. Enhanced Antibacterial effect of chitosan film using Montmorillonite/CuO nanocomposite10.1016/j.ijbiomac.2017.11.119 ↗
77. Chitosan based metallic nanocomposite scaffolds as antimicrobial wound dressings
78. Inspired by nature: facile design of nanoclay-organic hydrogel bone sealant with multifunctional properties for robust bone regeneration10.1002/adfm.202003717 ↗
79. Ag-doped magnetic metal organic framework as a novel nanostructured material for highly efficient antibacterial activity10.1016/j.envres.2020.109555 ↗
80. Delivery of antibiotics with polymeric particles10.1016/j.addr.2014.02.002 ↗
81. Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO)10.1039/C6BM00271D ↗
82. Recent advances in nitric oxide delivery for antimicrobial applications using polymer-based systems10.1039/C8TB00299A ↗
83. Antibacterial activity of silver nanoparticles: structural effects10.1002/adhm.201701503 ↗
84. One-pot synthesis and characterization of in-house engineered silver nanoparticles from Flacourtia jangomas fruit extract with effective antibacterial profiles10.1007/s40097-020-00354-w ↗
85. Antimicrobial activities of biologically synthesized metal nanoparticles: an insight into the mechanism of action10.1007/s00775-019-01717-7 ↗
86. Interactions of Gold and Silver Nanoparticles with Bacterial Biofilms: Molecular Interactions behind Inhibition and Resistance10.3390/ijms21207658 ↗
87. Antibacterial mechanism of silver nanoparticles in Pseudomonas aeruginosa: proteomics approach10.1039/C7MT00328E ↗
88. Synthesis and characterization of novel trimethyltin(IV) and tributylltin(IV) complexes of anticoagulant, WARFARIN: potential DNA binding and plasmid cleaving agents10.1016/j.inoche.2018.07.001 ↗
89. Polyion multilayers with precise surface charge control for antifouling10.1021/am507371a ↗
90. Preparation of organic-inorganic chitosan@silver/sepiolite composites with high synergistic antibacterial activity and stability10.1016/j.carbpol.2020.116858 ↗
91. Long-term prevention of bacterial infection and enhanced osteoinductivity of a hybrid coating with selective silver toxicity
92. Polymer assemblies for controlled delivery of bioactive molecules from surfaces10.1016/j.addr.2011.03.017 ↗
93. A glance at antimicrobial strategies to prevent catheter-associated medical infections10.1021/acsinfecdis.0c00526 ↗
94. Anti-adhesion and antiproliferative cellulose triacetate membrane for prevention of biomaterial-centred infections associated with Staphylococcus epidermidis10.1016/j.ijantimicag.2009.09.017 ↗
95. Antibacterial properties of sophorolipid-modified gold surfaces against Gram positive and Gram negative pathogens10.1016/j.colsurfb.2017.05.072 ↗
96. Competitive colonization of prosthetic surfaces bystaphylococcus aureusand human cells10.1002/jbm.a.35863 ↗
97. Polyurethane–polyvinylpyrrolidone iodine blends as potential urological biomaterials10.1007/s10853-018-2445-7 ↗
98. Bio-inspired strategies for designing antifouling biomaterials10.1186/s40824-016-0064-4 ↗
99. Adaptive antibacterial biomaterial surfaces and their applications
100. Bacteria-surface interactions10.1039/c3sm27705d ↗